Cell Therapy Services

ProBio is a full-service, end-to-end CDMO for cell therapy, with strong capabilities in plasmid and lentiviral vector (LVV) development and manufacturing. Our fast, integrated, globally compliant platforms with proprietary technologies, reduce complexity and enable faster progression to clinic. Our 6-month one stop solution for IND filing is supported by proprietary platforms that increase standardization, reliability and are globally compliant with regulations, to smooth the path to approval. Performance efficiency is supported by high yield across the platform, ultimately resulting in lower cost per batch. Our global facilities have quality built in from the start, de‑risking development and driving cost efficiency through our platform processes. Over 90 IND approvals globally Proven experience across FDA and NMPA Over 900 clinical batches delivered Experience in supporting multiple client programs across CAR-T, mRNA and viral vectors